Literature DB >> 23971259

Perinatal outcome of singleton pregnancies following in vitro fertilization.

J Stojnic1, N Radunovic, K Jeremic, B Kastratovic Kotlica, M Mitrovic, I Tulic.   

Abstract

PURPOSE OF INVESTIGATION: To determine whether in vitro fertilization/intracytoplasmatic sperm injection (IVF/ICSI) singleton pregnancies are at increased risk for maternal and fetal complications than spontaneous singleton conceptions.
MATERIALS AND METHODS: The pregnancy outcome of 634 singleton pregnancies after IVF/ICSI delivered at the Clinic for Gynecology and Obstetrics during the period January 2006 to January 2010 were compared to 634 matched singleton controls, matched one by one by age, parity, education, and body mass index (BMI). Differences in pregnancy outcomes between the groups were assessed using Student's t-test with Yates correction for continuous variables and Chi-squared test for categorical variables.
RESULTS: The mean gestational age at delivery of the IVF group was 38.13 +/- 1.72 weeks, slightly shorter than spontaneously conceived singletons at 38.65 +/- 1.79 weeks. The diagnosis of gestational diabetes mellitus (GDM) was frequently made in the IVF group (11.82% vs 8.35%, t = 2.052, p < 0.05). Total preterm delivery rate of IVF pregnancies was 9.30%, significantly higher than the controls 5.85% (t = 2.33, p < 0.05), especially at the 30-32 weeks gestation period. The predominant mode of delivery after IVF pregnancy was cesarean section (80.75% vs 31.38% at spontaneously conceived, t = 17.71, p < 0.001), while vaginal route was the choice for naturally originated pregnancies 68.6% vs 19.24% (p < 0.01). No differences were found in the average birth weights, LBW, VLBW, SGA, and LGA regarding the pregnancy origin. Perinatal mortality rates were comparable among singletons with different pregnancy origin.
CONCLUSIONS: Singletons from IVF/ICSI pregnancies have poorer perinatal outcome associated with higher rates of cesarean sections, preterm birth and prematurity, fetal malpresentation (breech presentation), and the occurrence of maternal GDM in pregnancy.

Entities:  

Mesh:

Year:  2013        PMID: 23971259

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  6 in total

1.  Comparison of effects of nifedipine and ritodrine on maternal and fetal blood flow patterns in preterm labor.

Authors:  Baran Özhan Baykal; Sümeyra Nergiz Avcıoğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-06-01

2.  The association between temporal changes in the use of obstetrical intervention and small-for-gestational age live births.

Authors:  Amy Metcalfe; Sarka Lisonkova; K S Joseph
Journal:  BMC Pregnancy Childbirth       Date:  2015-09-29       Impact factor: 3.007

3.  Identifying Maternal Constraints on Fetal Growth and Subsequent Perinatal Outcomes Using a Multiple Embryo Implantation Model.

Authors:  Nigel Pereira; Tyler Cozzubbo; Stephanie Cheung; Zev Rosenwaks; Gianpiero D Palermo; Queenie V Neri
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

4.  Pregnant after assisted reproduction: a risk pregnancy is born! 18-years perinatal outcome results from a population-based registry in Flanders, Belgium.

Authors:  W Ombelet; G Martens; L Bruckers
Journal:  Facts Views Vis Obgyn       Date:  2016-12

5.  Risk of gestational diabetes mellitus in women achieving singleton pregnancy spontaneously or after ART: a systematic review and meta-analysis.

Authors:  Julia K Bosdou; Panagiotis Anagnostis; Dimitrios G Goulis; Georgios T Lainas; Basil C Tarlatzis; Grigoris F Grimbizis; Efstratios M Kolibianakis
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

6.  Caesarean section in pregnancies conceived by assisted reproductive technology: a systematic review and meta-analysis.

Authors:  Nakeisha A Lodge-Tulloch; Flavia T S Elias; Jessica Pudwell; Laura Gaudet; Mark Walker; Graeme N Smith; Maria P Velez
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-22       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.